Cargando…

Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status

BACKGROUND: Subjective cognitive decline (SCD) is a target for Alzheimer’s disease prediction. Plasma amyloid-beta oligomer (AβO), the pathogenic form of Aβ in blood, has recently been proposed as a novel blood-based biomarker of AD prediction by representing brain Aβ deposition. The relationship be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Keun You, Park, Jaesub, Jeong, Yong Hyu, Kim, Hyun Jeong, Lee, Eun, Park, Jin Young, Kim, Eosu, Kim, Woo Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632136/ https://www.ncbi.nlm.nih.gov/pubmed/36324157 http://dx.doi.org/10.1186/s13195-022-01104-6

Ejemplares similares

Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology
por: Kim, Keun You, et al.
Publicado: (2022)

Evaluation of glymphatic system activity using diffusion tensor image analysis along the perivascular space and amyloid PET in older adults with objectively normal cognition: a preliminary study
por: Park, Chae Jung, et al.
Publicado: (2023)

Immunogenic properties of amyloid beta oligomers
por: Dalgediene, Indre, et al.
Publicado: (2013)

Clinical Significance of Physical Frailty in Subjects With Subjective Cognitive Decline: A Prospective Study With Amyloid PET Data
por: Lim, Eun Ye, et al.
Publicado: (2023)

Role of Lipocalin-2 in Amyloid-Beta Oligomer-Induced Mouse Model of Alzheimer’s Disease
por: Kang, Heeyoung, et al.
Publicado: (2021)

Involvement of amygdala–prefrontal dysfunction in the influence of negative emotion on the resolution of cognitive conflict in patients with schizophrenia
por: Park, Jaesub, et al.
Publicado: (2018)

Sleep is bi-directionally modified by amyloid beta oligomers
por: Özcan, Güliz Gürel, et al.
Publicado: (2020)

Altered metamemory precedes cognitive impairment in subjective cognitive decline with positive amyloid-beta
por: Li, QinJie, et al.
Publicado: (2022)

Association Between Plasma Amyloid-β and Neuropsychological Performance in Patients With Cognitive Decline
por: Yun, Gyihyaon, et al.
Publicado: (2021)

Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer’s disease
por: An, Seong Soo A., et al.
Publicado: (2023)

Cognitive decline according to amyloid uptake in patients with poststroke cognitive impairment
por: Yoon, Bora, et al.
Publicado: (2021)

Bioactive Compounds in Kimchi Improve the Cognitive and Memory Functions Impaired by Amyloid Beta
por: Woo, Minji, et al.
Publicado: (2018)

Application of an Amyloid Beta Oligomer Standard in the sFIDA Assay
por: Kühbach, Katja, et al.
Publicado: (2016)

Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers
por: Fernandez‐Perez, Eduardo J., et al.
Publicado: (2021)

Editorial: Beta-Amyloid oligomer specific treatments for Alzheimer's disease
por: Hillen, Heinz
Publicado: (2023)

Actual memory as a mediator of the amyloid-subjective cognitive decline relationship
por: Chen, Xi, et al.
Publicado: (2019)

Interaction of CSF α‐synuclein and amyloid beta in cognition and cortical atrophy
por: Lee, Young‐gun, et al.
Publicado: (2021)

Characteristics of subjective cognitive decline associated with amyloid positivity
por: Janssen, Olin, et al.
Publicado: (2021)

The Toxicity of Amyloid β Oligomers
por: Zhao, Li Na, et al.
Publicado: (2012)

Amyloid Depositions and Small Vessel Disease in Patients with Cerebral Amyloid Angiopathy: a Case Series
por: Hong, Yun Jeong, et al.
Publicado: (2020)

Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia
por: Sondag, Cindy M, et al.
Publicado: (2009)

Quantitative analysis of co-oligomer formation by amyloid-beta peptide isoforms
por: Iljina, Marija, et al.
Publicado: (2016)

Near infrared light decreases synaptic vulnerability to amyloid beta oligomers
por: Comerota, Michele M., et al.
Publicado: (2017)

Corrigendum: Synaptic dysregulation and hyperexcitability induced by intracellular amyloid beta oligomers
Publicado: (2021)

Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults
por: Farrell, Michelle E., et al.
Publicado: (2018)

Non-linear Character of Plasma Amyloid Beta Over the Course of Cognitive Decline in Alzheimer’s Continuum
por: Pan, Feng-Feng, et al.
Publicado: (2022)

Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology
por: Wang, Pei‐Ning, et al.
Publicado: (2020)

Sectoral segmentation of retinal amyloid imaging in subjects with cognitive decline
por: Dumitrascu, Oana M., et al.
Publicado: (2020)

Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)
por: de Rojas, Itziar, et al.
Publicado: (2018)

Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates
por: Sharoar, Md Golam, et al.
Publicado: (2012)

An N-terminal antibody promotes the transformation of amyloid fibrils into oligomers and enhances the neurotoxicity of amyloid-beta: the dust-raising effect
por: Liu, Yu-Hui, et al.
Publicado: (2015)

TonEBP Haploinsufficiency Attenuates Microglial Activation and Memory Deficits in Middle-Aged and Amyloid β Oligomer-Treated Mice
por: Lee, Jong Youl, et al.
Publicado: (2023)

Cognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy
por: Huber, Colin M., et al.
Publicado: (2017)

A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers
por: Sun, Liping, et al.
Publicado: (2018)

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers
por: Sardar Sinha, Maitrayee, et al.
Publicado: (2018)

Is postoperative cognitive decline after cardiac surgery associated with plasma beta amyloid 1–42 levels?
por: Požgain, Zrinka, et al.
Publicado: (2022)

Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin
por: Shin, Thuzar M, et al.
Publicado: (2008)

Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers
por: Jang, Hyemin, et al.
Publicado: (2019)

Breaking the Code of Amyloid-β Oligomers
por: Lesné, Sylvain E.
Publicado: (2013)

The Toxicity and Polymorphism of β-Amyloid Oligomers
por: Huang, Ya-ru, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bj31oalpvgrlt0pmd4ajjtrfa2